Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is used in the research on inflammatory diseases, cancer, and AIDS.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 39.00 | |
2 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 153.00 | |
25 mg | In stock | $ 315.00 | |
50 mg | In stock | $ 455.00 | |
100 mg | In stock | $ 555.00 | |
200 mg | In stock | $ 798.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 97.00 |
Description | ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is used in the research on inflammatory diseases, cancer, and AIDS. |
Targets&IC50 | BRD4 BD2:3 nM (Kd), BRD4 BD2:4 nM (IC50), BRD3 BD2:13 nM (IC50), BRDT BD2:18 nM (IC50), BRD2 BD2:8 nM (IC50) |
Synonyms | ABBV744 |
Molecular Weight | 491.55 |
Formula | C28H30FN3O4 |
CAS No. | 2138861-99-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (91.54 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABBV-744 2138861-99-9 Chromatin/Epigenetic Microbiology/Virology Proteases/Proteasome Epigenetic Reader Domain HIV Protease Inhibitor Antitumor Selective Oral inhibit Potent ABBV744 Drug-like Human immunodeficiency virus LNCaP CYP3A4 HIV ABBV 744 inhibitor